fbpx

20 Years of Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.

Clinical BioBanking
With over 20 years of providing cord blood to banks hospitals, researchers and stem clinicians with systems designed to handle stem cells with the highest level of precision, safety, and confidence.
Point-of-Care Solutions
We develop products to obtain bone marrow concentrates easily, consistently, and reliably from bone marrow aspirates at the point-of-care with minimal red blood cell contamination.
Cellular Processing
The first step in the process is often the most important. That's why we have created closed-system novel and innovative technologies aimed at advancing cell therapies to the clinic.

Recent News

The Successes and Challenges of CAR T-cell Therapy 

The four pillars of cancer treatment have always been surgery, chemotherapy, radiation therapy and targeted therapy. Recently, there have been developments leading to what scientists and medical professionals are referring to as the fifth pillar — immunotherapy.  Immunotherapy, or therapy that utilizes a patient’s own immune system to help illnesses, has been proven to be … Continued

Bone Marrow Aspirate Concentrate vs. Surgical Intervention

From injuries that can happen in an instant to normal wear-and-tear from physical activity over time, when there is something wrong with your joints or ligaments, it can cause discomfort and pain that can severely disrupt your way of life. Sometimes, the best way to correct these issues is through surgery, but many physicians will … Continued

ThermoGenesis Holdings to Participate at the H.C. Wainwright BIOCONNECT 2021 Conference

RANCHO CORDOVA, Calif., Jan. 7, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble, Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference. The presentation will be available beginning January … Continued

The Role Testing Plays in the Management of the COVID-19 Pandemic

Testing has played one of the most crucial roles in managing this current global COVID-19 pandemic so far. From helping identify active cases, to tracking those who have been infected and, ultimately, mitigating the spread. Throughout the history of modern medicine, testing has been one of the main tools public health officials have turned to … Continued

ThermoGenesis Provides Regenerative Medicine Solutions

Regenerative medicine is a term that refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. It is the process of replacing or “regenerating” human cells, tissues or organs to restore, or establish, normal function. The human body is an incredible machine, equipped with the ability to … Continued

Answering Your COVID-19 Testing Questions

With the number of COVID-19 cases rapidly rising, it is important to stay up to date with accurate information surrounding coronavirus testing. Throughout this global pandemic, the internet along with the media have played an essential role in facilitating how we receive information and updates regarding the coronavirus (SARS-CoV-2). Sometimes the information presented is somewhat … Continued

Click below and be the first to hear about the latest news, breakthroughs, and products with the ThermoGenesis newsletter delivered directly to your inbox.
How may we help?